Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance

International Journal of Obesity

Volumn 27, Issue , 2003, Pages S49-S52

  Shoelson, S E ^a   Lee, J ^a   Yuan, M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Kinases; Salicylates

Indexed keywords

ACETYLSALICYLIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLIC ACID DERIVATIVE;

CONFERENCE PAPER; CORRELATION ANALYSIS; DIETARY INTAKE; DOSE RESPONSE; ENZYME ACTIVATION; GENE DELETION; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER TOXICITY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DIETARY FATS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INSULIN RESISTANCE; MICE; NF-KAPPA B; OBESITY; PROTEIN-SERINE-THREONINE KINASES; RATS; SALICYLATES;

ANIMALIA; RODENTIA;

EID: 0346880505     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802501     Document Type: Article

References (20)

1. Ebstein W. Zur therapie des diabetes mellitus, insbesondere uber die anwendeng der salicylauren natron bei demselben. Berlin Klin Wochnschrift 1876; 13: 337–340.
2. Williamson RT. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. BMJ 1901; 1: 760–762.
3. Reid J, Macdougall AI, Andrews MM. On the efficacy of salicylate in treating diabetes mellitus. BMJ 1957; 2: 1071–1074.
4. Gilgore SG. The influence of salicylate on hyperglycemia. Diabetes 1960; 9: 392–393.
5. Hecht A, Goldner MG. Reappraisal of the hypoglycemic action of acetylsalicylate. Metabolism 1959; 8: 418–428.
6. Baron SH. Salicylates as hypoglycemic agents. Diabetes Care 1982; 5: 64–71.
7. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
8. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity–diabetes link. Diabetes 1994; 43: 1271–1278.
9. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000; 24 (Suppl 4): S23–S27.
10. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956–959.
11. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 1998; 396: 77–80.
12. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 2001; 293: 1673–1677.
13. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284: 321–325.
14. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M. The IKKβ subunit of IκB kinase (IKK) is essential for NFκB activation and prevention of apoptosis. J Exp Med 1999; 189: 1839–1845.
15. Boden G. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin N Am 2001; 30: 801–815.
16. Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 2002; 90: 11G–18G.
17. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acidinduced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270–1274.
18. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005–2011.
19. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108: 437–446.
20. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109: 1321–1326.